Modulators of 5′-nucleotidase, ecto and the use thereof
US-12459967-B2 · Nov 4, 2025 · US
This page is not indexed by search engines while we improve data quality.
Powers Jay Patrick patents
Powers Jay Patrick is listed as an inventor on 60 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Powers Jay Patrick |
| Total patents | 60 |
| First publication | Sep 21, 2017 |
| Latest publication | Nov 4, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibitors of adenosine 5'-nucleotidase
US-2025319113-A1 · Oct 16, 2025 · US
Parenterally administered immune enhancing drugs
US-12433836-B2 · Oct 7, 2025 · US
Amorphous and crystalline forms of IDO inhibitors
US-12421195-B2 · Sep 23, 2025 · US
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
US-12410170-B2 · Sep 9, 2025 · US
Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha
US-2025214930-A1 · Jul 3, 2025 · US
Inhibitors of ARG1 and/or ARG2
US-12226425-B2 · Feb 18, 2025 · US
Compounds as inhibitors of AXL
US-12195482-B1 · Jan 14, 2025 · US
Compounds as inhibitors of axl
US-2024425526-A1 · Dec 26, 2024 · US
Inhibitors of adenosine 5′-nucleotidase
US-12168023-B2 · Dec 17, 2024 · US
Recent patents
Latest publications not already listed above.
Modulators of 5'-nucleotidase, ecto and the use thereof
US-2024352057-A1 · Oct 24, 2024 · US
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
US-12103907-B2 · Oct 1, 2024 · US
Inhibitors of adenosine 5'-nucleotidase
US-2024285665-A1 · Aug 29, 2024 · US
Inhibitors of HIF-2α and methods of use thereof
US-12071411-B2 · Aug 27, 2024 · US
Pyridone A2R antagonists
US-12064433-B2 · Aug 20, 2024 · US
Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha
US-2024254079-A1 · Aug 1, 2024 · US
Axl compounds
US-2024246967-A1 · Jul 25, 2024 · US
Axl inhibitor compounds
US-2024226115-A1 · Jul 11, 2024 · US
Solid forms of an azolopyrimidine compound
US-11993584-B2 · May 28, 2024 · US
Inhibitors of hpk1 and methods of use thereof
US-2024124490-A1 · Apr 18, 2024 · US
CD73 inhibitors
US-11931343-B2 · Mar 19, 2024 · US
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
US-11919863-B2 · Mar 5, 2024 · US
Compounds as inhibitors of axl
US-2023416277-A1 · Dec 28, 2023 · US
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
US-11787762-B2 · Oct 17, 2023 · US
Modulators of 5′-nucleotidase, ecto and the use thereof
US-11667662-B2 · Jun 6, 2023 · US
Inhibitors of hif-2alpha and methods of use thereof
US-2023159466-A1 · May 25, 2023 · US
Oral formulations of CD73 compounds
US-11633416-B1 · Apr 25, 2023 · US
Inhibitors of hif-2alpha
US-2023024438-A1 · Jan 26, 2023 · US
Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha
US-2023021476-A1 · Jan 26, 2023 · US
2,3,5-trisubstituted pyrazolo[1,5-a]pyrimidine compounds
US-2023024302-A1 · Jan 26, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Arcus Biosciences Inc | 50 |
| Bristol Myers Squibb Co | 8 |
| Bristol Myers Squibb Co | 1 |
| Arcus Biosciences Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 52 |
| A61K45/06 | 46 |
| C07D487/04 | 25 |
| A61P29/00 | 22 |
| A61K39/3955 | 19 |